EUVIMEDEUVIMED entdecken
Crossref

Primary adrenal sarcomas: A national analysis of epidemiological trends, treatment patterns, and outcomes

Bibek Aryal, Samantha Falls, Yue Yin, Patrick L Wagner, David L Bartlett, Rodney E Wegner, Casey J Allen

Journal of Surgical Oncology · 2024

DOI: 10.1002/jso.27836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Bibek Aryal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Allegheny Singer Research Institute, Allegheny Health Network, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Sarcoma, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Primary adrenal sarcoma (PAS) is an exceedingly rare malignancy with limited data available on its epidemiology, management, and outcomes. This study aimed to characterize the national incidence, treatment patterns, and survival of PAS utilizing a National Cancer Database.

Methods

The National Cancer Database was queried for patients diagnosed with primary adrenal tumors from 2004 to 2019. Cases with sarcoma histology were identified as PAS. Annual incidence trends, histological distribution, treatment modalities (surgery, chemotherapy, radiation therapy), perioperative outcomes, and overall survival (OS) were analyzed.

Results

Of 7213 primary adrenal tumor cases, 332 (4.6%) were PAS. The most common histological subtypes were leiomyosarcoma (37.3%), hemangiosarcoma (27.1%), and sarcoma not otherwise specified (6.0%). Most cases (71.7%) presented as locoregional disease. Treatment included surgery alone (47.8%), surgery plus chemotherapy and/or radiation (27.1%), chemotherapy/radiation alone (13.3%), or no treatment (13.9%). For surgical cases, the median length of stay was 5 days, the 30‐day readmission rate was 3.36%, and the 30/90‐day mortality rates were 3.65% and 9.90%, respectively. The 5‐year OS rate for surgery alone was 43%, with a median OS of 34.6 months. For surgery with radiation/chemotherapy, the 5‐year OS rate was 37.3%, with a median OS of 35.4 months.

Conclusions

This largest analysis of PAS to date demonstrates that most cases present as locoregional disease amenable to surgical resection, with favorable outcomes. The role of adjuvant therapy remains unclear, as no significant survival difference was observed between surgery alone and multimodal treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaAdrenal Gland NeoplasmsHumansFemaleMaleMiddle AgedAgedUnited StatesAdultSurvival RateIncidenceYoung AdultCombined Modality TherapyRetrospective StudiesAdolescentFollow-Up StudiesDatabases, FactualTreatment OutcomeAged, 80 and over

Stichwörter der Autor:innen

National Cancer Databaseadrenal neoplasmsprimary adrenal sarcomasarcoma histologytreatment outcomes

Autor:innen und Institutionen

  • Allegheny Singer Research Institute, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
  • Surgery Institute, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
  • Cancer Institute, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.

Zitieren

APA

Aryal, B., Falls, S., Yin, Y., Wagner, P. L., Bartlett, D. L., Wegner, R. E., & Allen, C. J. (2024). Primary adrenal sarcomas: A national analysis of epidemiological trends, treatment patterns, and outcomes. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27836

Vancouver

Aryal B, Falls S, Yin Y, Wagner PL, Bartlett DL, Wegner RE, et al. Primary adrenal sarcomas: A national analysis of epidemiological trends, treatment patterns, and outcomes. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27836

BibTeX
@article{Aryal2024,
  author = {Aryal, Bibek and Falls, Samantha and Yin, Yue and Wagner, Patrick L and Bartlett, David L and Wegner, Rodney E and Allen, Casey J},
  title = {Primary adrenal sarcomas: A national analysis of epidemiological trends, treatment patterns, and outcomes},
  journal = {Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1002/jso.27836}
}
Kostenlos starten →